0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Rapid Testing for Respiratory Pathogens- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: September 2025
|
Report Code: QYRE-Auto-3E15787
Home | Market Reports | Health| Public Health
Global Rapid Testing for Respiratory Pathogens Market Research Report 2023
BUY CHAPTERS

Rapid Testing for Respiratory Pathogens- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-3E15787
Report
September 2025
Pages:152
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rapid Testing for Respiratory Pathogens- Market Size

The global market for Rapid Testing for Respiratory Pathogens was estimated to be worth US$ 696 million in 2024 and is forecast to a readjusted size of US$ 1014 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.

Rapid Testing for Respiratory Pathogens- Market

Rapid Testing for Respiratory Pathogens- Market

Rapid Testing for Respiratory Pathogens is a method or device for rapid detection of respiratory pathogens. This test is typically used in clinical healthcare settings and is designed to quickly determine whether a patient is infected with a specific respiratory pathogen. While traditional diagnostic methods can take days to deliver results, rapid respiratory pathogen testing can provide results in a shorter timeframe, often providing initial screening results within a few hours or instantly.
North American market for Rapid Testing for Respiratory Pathogens was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rapid Testing for Respiratory Pathogens was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Rapid Testing for Respiratory Pathogens was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Rapid Testing for Respiratory Pathogens include Eurofins Scientific, Charles River, Genesystem, Thermo Fisher Scientific, BIOTECON Diagnostics, Qiagen, Anatolia Geneworks, Romer Labs, Beijing Innotech Biotechnology Co., Ltd., Livzon Reagent, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Testing for Respiratory Pathogens, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rapid Testing for Respiratory Pathogens by region & country, by Type, and by Application.
The Rapid Testing for Respiratory Pathogens market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Testing for Respiratory Pathogens.
Market Segmentation

Scope of Rapid Testing for Respiratory Pathogens- Market Report

Report Metric Details
Report Name Rapid Testing for Respiratory Pathogens- Market
Forecasted market size in 2031 US$ 1014 million
CAGR 5.6%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Charles River, Genesystem, Thermo Fisher Scientific, BIOTECON Diagnostics, Qiagen, Anatolia Geneworks, Romer Labs, Beijing Innotech Biotechnology Co., Ltd., Livzon Reagent, Sanxiang Biology, Wondfo Bio, Wantai Bio, Oriental Creatures, Zhuo Cheng Huisheng, Hirsch, Boao Crystal Core, Wuhan Zhongqi, Yahuilong, Anxu Biology, Botuo Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Rapid Testing for Respiratory Pathogens company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Rapid Testing for Respiratory Pathogens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Rapid Testing for Respiratory Pathogens in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Rapid Testing for Respiratory Pathogens- Market size in 2031?

Ans: The Rapid Testing for Respiratory Pathogens- Market size in 2031 will be US$ 1014 million.

Who are the main players in the Rapid Testing for Respiratory Pathogens- Market report?

Ans: The main players in the Rapid Testing for Respiratory Pathogens- Market are Eurofins Scientific, Charles River, Genesystem, Thermo Fisher Scientific, BIOTECON Diagnostics, Qiagen, Anatolia Geneworks, Romer Labs, Beijing Innotech Biotechnology Co., Ltd., Livzon Reagent, Sanxiang Biology, Wondfo Bio, Wantai Bio, Oriental Creatures, Zhuo Cheng Huisheng, Hirsch, Boao Crystal Core, Wuhan Zhongqi, Yahuilong, Anxu Biology, Botuo Biological

What are the Application segmentation covered in the Rapid Testing for Respiratory Pathogens- Market report?

Ans: The Applications covered in the Rapid Testing for Respiratory Pathogens- Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Rapid Testing for Respiratory Pathogens- Market report?

Ans: The Types covered in the Rapid Testing for Respiratory Pathogens- Market report are PCR Detection, RDT Detection, Other

Recommended Reports

Rapid Diagnostic Testing

Respiratory Diagnostics

Pathogen Detection

1 Market Overview
1.1 Rapid Testing for Respiratory Pathogens Product Introduction
1.2 Global Rapid Testing for Respiratory Pathogens Market Size Forecast (2020-2031)
1.3 Rapid Testing for Respiratory Pathogens Market Trends & Drivers
1.3.1 Rapid Testing for Respiratory Pathogens Industry Trends
1.3.2 Rapid Testing for Respiratory Pathogens Market Drivers & Opportunity
1.3.3 Rapid Testing for Respiratory Pathogens Market Challenges
1.3.4 Rapid Testing for Respiratory Pathogens Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rapid Testing for Respiratory Pathogens Players Revenue Ranking (2024)
2.2 Global Rapid Testing for Respiratory Pathogens Revenue by Company (2020-2025)
2.3 Key Companies Rapid Testing for Respiratory Pathogens Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rapid Testing for Respiratory Pathogens Product Offered
2.5 Key Companies Time to Begin Mass Production of Rapid Testing for Respiratory Pathogens
2.6 Rapid Testing for Respiratory Pathogens Market Competitive Analysis
2.6.1 Rapid Testing for Respiratory Pathogens Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Rapid Testing for Respiratory Pathogens Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Testing for Respiratory Pathogens as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR Detection
3.1.2 RDT Detection
3.1.3 Other
3.2 Global Rapid Testing for Respiratory Pathogens Sales Value by Type
3.2.1 Global Rapid Testing for Respiratory Pathogens Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Rapid Testing for Respiratory Pathogens Sales Value, by Type (2020-2031)
3.2.3 Global Rapid Testing for Respiratory Pathogens Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Rapid Testing for Respiratory Pathogens Sales Value by Application
4.2.1 Global Rapid Testing for Respiratory Pathogens Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Rapid Testing for Respiratory Pathogens Sales Value, by Application (2020-2031)
4.2.3 Global Rapid Testing for Respiratory Pathogens Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Rapid Testing for Respiratory Pathogens Sales Value by Region
5.1.1 Global Rapid Testing for Respiratory Pathogens Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Rapid Testing for Respiratory Pathogens Sales Value by Region (2020-2025)
5.1.3 Global Rapid Testing for Respiratory Pathogens Sales Value by Region (2026-2031)
5.1.4 Global Rapid Testing for Respiratory Pathogens Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
5.2.2 North America Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
5.3.2 Europe Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
5.4.2 Asia Pacific Rapid Testing for Respiratory Pathogens Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
5.5.2 South America Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
5.6.2 Middle East & Africa Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rapid Testing for Respiratory Pathogens Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.3 United States
6.3.1 United States Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.3.2 United States Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.4.2 Europe Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.5.2 China Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.5.3 China Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.6.2 Japan Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.7.2 South Korea Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.8.2 Southeast Asia Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Rapid Testing for Respiratory Pathogens Sales Value, 2020-2031
6.9.2 India Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
6.9.3 India Rapid Testing for Respiratory Pathogens Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Profile
7.1.2 Eurofins Scientific Main Business
7.1.3 Eurofins Scientific Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.1.4 Eurofins Scientific Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.1.5 Eurofins Scientific Recent Developments
7.2 Charles River
7.2.1 Charles River Profile
7.2.2 Charles River Main Business
7.2.3 Charles River Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.2.4 Charles River Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.2.5 Charles River Recent Developments
7.3 Genesystem
7.3.1 Genesystem Profile
7.3.2 Genesystem Main Business
7.3.3 Genesystem Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.3.4 Genesystem Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.3.5 Genesystem Recent Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Profile
7.4.2 Thermo Fisher Scientific Main Business
7.4.3 Thermo Fisher Scientific Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.4.5 Thermo Fisher Scientific Recent Developments
7.5 BIOTECON Diagnostics
7.5.1 BIOTECON Diagnostics Profile
7.5.2 BIOTECON Diagnostics Main Business
7.5.3 BIOTECON Diagnostics Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.5.4 BIOTECON Diagnostics Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.5.5 BIOTECON Diagnostics Recent Developments
7.6 Qiagen
7.6.1 Qiagen Profile
7.6.2 Qiagen Main Business
7.6.3 Qiagen Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.6.4 Qiagen Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.6.5 Qiagen Recent Developments
7.7 Anatolia Geneworks
7.7.1 Anatolia Geneworks Profile
7.7.2 Anatolia Geneworks Main Business
7.7.3 Anatolia Geneworks Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.7.4 Anatolia Geneworks Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.7.5 Anatolia Geneworks Recent Developments
7.8 Romer Labs
7.8.1 Romer Labs Profile
7.8.2 Romer Labs Main Business
7.8.3 Romer Labs Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.8.4 Romer Labs Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.8.5 Romer Labs Recent Developments
7.9 Beijing Innotech Biotechnology Co., Ltd.
7.9.1 Beijing Innotech Biotechnology Co., Ltd. Profile
7.9.2 Beijing Innotech Biotechnology Co., Ltd. Main Business
7.9.3 Beijing Innotech Biotechnology Co., Ltd. Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.9.4 Beijing Innotech Biotechnology Co., Ltd. Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.9.5 Beijing Innotech Biotechnology Co., Ltd. Recent Developments
7.10 Livzon Reagent
7.10.1 Livzon Reagent Profile
7.10.2 Livzon Reagent Main Business
7.10.3 Livzon Reagent Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.10.4 Livzon Reagent Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.10.5 Livzon Reagent Recent Developments
7.11 Sanxiang Biology
7.11.1 Sanxiang Biology Profile
7.11.2 Sanxiang Biology Main Business
7.11.3 Sanxiang Biology Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.11.4 Sanxiang Biology Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.11.5 Sanxiang Biology Recent Developments
7.12 Wondfo Bio
7.12.1 Wondfo Bio Profile
7.12.2 Wondfo Bio Main Business
7.12.3 Wondfo Bio Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.12.4 Wondfo Bio Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.12.5 Wondfo Bio Recent Developments
7.13 Wantai Bio
7.13.1 Wantai Bio Profile
7.13.2 Wantai Bio Main Business
7.13.3 Wantai Bio Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.13.4 Wantai Bio Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.13.5 Wantai Bio Recent Developments
7.14 Oriental Creatures
7.14.1 Oriental Creatures Profile
7.14.2 Oriental Creatures Main Business
7.14.3 Oriental Creatures Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.14.4 Oriental Creatures Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.14.5 Oriental Creatures Recent Developments
7.15 Zhuo Cheng Huisheng
7.15.1 Zhuo Cheng Huisheng Profile
7.15.2 Zhuo Cheng Huisheng Main Business
7.15.3 Zhuo Cheng Huisheng Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.15.4 Zhuo Cheng Huisheng Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.15.5 Zhuo Cheng Huisheng Recent Developments
7.16 Hirsch
7.16.1 Hirsch Profile
7.16.2 Hirsch Main Business
7.16.3 Hirsch Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.16.4 Hirsch Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.16.5 Hirsch Recent Developments
7.17 Boao Crystal Core
7.17.1 Boao Crystal Core Profile
7.17.2 Boao Crystal Core Main Business
7.17.3 Boao Crystal Core Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.17.4 Boao Crystal Core Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.17.5 Boao Crystal Core Recent Developments
7.18 Wuhan Zhongqi
7.18.1 Wuhan Zhongqi Profile
7.18.2 Wuhan Zhongqi Main Business
7.18.3 Wuhan Zhongqi Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.18.4 Wuhan Zhongqi Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.18.5 Wuhan Zhongqi Recent Developments
7.19 Yahuilong
7.19.1 Yahuilong Profile
7.19.2 Yahuilong Main Business
7.19.3 Yahuilong Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.19.4 Yahuilong Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.19.5 Yahuilong Recent Developments
7.20 Anxu Biology
7.20.1 Anxu Biology Profile
7.20.2 Anxu Biology Main Business
7.20.3 Anxu Biology Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.20.4 Anxu Biology Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.20.5 Anxu Biology Recent Developments
7.21 Botuo Biological
7.21.1 Botuo Biological Profile
7.21.2 Botuo Biological Main Business
7.21.3 Botuo Biological Rapid Testing for Respiratory Pathogens Products, Services and Solutions
7.21.4 Botuo Biological Rapid Testing for Respiratory Pathogens Revenue (US$ Million) & (2020-2025)
7.21.5 Botuo Biological Recent Developments
8 Industry Chain Analysis
8.1 Rapid Testing for Respiratory Pathogens Industrial Chain
8.2 Rapid Testing for Respiratory Pathogens Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rapid Testing for Respiratory Pathogens Sales Model
8.5.2 Sales Channel
8.5.3 Rapid Testing for Respiratory Pathogens Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Rapid Testing for Respiratory Pathogens Market Trends
 Table 2. Rapid Testing for Respiratory Pathogens Market Drivers & Opportunity
 Table 3. Rapid Testing for Respiratory Pathogens Market Challenges
 Table 4. Rapid Testing for Respiratory Pathogens Market Restraints
 Table 5. Global Rapid Testing for Respiratory Pathogens Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Rapid Testing for Respiratory Pathogens Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Rapid Testing for Respiratory Pathogens Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Rapid Testing for Respiratory Pathogens Product Type
 Table 9. Key Companies Time to Begin Mass Production of Rapid Testing for Respiratory Pathogens
 Table 10. Global Rapid Testing for Respiratory Pathogens Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Testing for Respiratory Pathogens as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Rapid Testing for Respiratory Pathogens Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Rapid Testing for Respiratory Pathogens Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Rapid Testing for Respiratory Pathogens Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Rapid Testing for Respiratory Pathogens Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Rapid Testing for Respiratory Pathogens Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Rapid Testing for Respiratory Pathogens Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Rapid Testing for Respiratory Pathogens Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Rapid Testing for Respiratory Pathogens Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Rapid Testing for Respiratory Pathogens Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Rapid Testing for Respiratory Pathogens Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Rapid Testing for Respiratory Pathogens Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Rapid Testing for Respiratory Pathogens Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Rapid Testing for Respiratory Pathogens Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Rapid Testing for Respiratory Pathogens Sales Value by Region (2020-2025) & (%)
 Table 27. Global Rapid Testing for Respiratory Pathogens Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Rapid Testing for Respiratory Pathogens Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Rapid Testing for Respiratory Pathogens Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Rapid Testing for Respiratory Pathogens Sales Value, (2026-2031) & (US$ Million)
 Table 31. Eurofins Scientific Basic Information List
 Table 32. Eurofins Scientific Description and Business Overview
 Table 33. Eurofins Scientific Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Eurofins Scientific (2020-2025)
 Table 35. Eurofins Scientific Recent Developments
 Table 36. Charles River Basic Information List
 Table 37. Charles River Description and Business Overview
 Table 38. Charles River Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Charles River (2020-2025)
 Table 40. Charles River Recent Developments
 Table 41. Genesystem Basic Information List
 Table 42. Genesystem Description and Business Overview
 Table 43. Genesystem Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Genesystem (2020-2025)
 Table 45. Genesystem Recent Developments
 Table 46. Thermo Fisher Scientific Basic Information List
 Table 47. Thermo Fisher Scientific Description and Business Overview
 Table 48. Thermo Fisher Scientific Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Thermo Fisher Scientific (2020-2025)
 Table 50. Thermo Fisher Scientific Recent Developments
 Table 51. BIOTECON Diagnostics Basic Information List
 Table 52. BIOTECON Diagnostics Description and Business Overview
 Table 53. BIOTECON Diagnostics Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of BIOTECON Diagnostics (2020-2025)
 Table 55. BIOTECON Diagnostics Recent Developments
 Table 56. Qiagen Basic Information List
 Table 57. Qiagen Description and Business Overview
 Table 58. Qiagen Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Qiagen (2020-2025)
 Table 60. Qiagen Recent Developments
 Table 61. Anatolia Geneworks Basic Information List
 Table 62. Anatolia Geneworks Description and Business Overview
 Table 63. Anatolia Geneworks Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Anatolia Geneworks (2020-2025)
 Table 65. Anatolia Geneworks Recent Developments
 Table 66. Romer Labs Basic Information List
 Table 67. Romer Labs Description and Business Overview
 Table 68. Romer Labs Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Romer Labs (2020-2025)
 Table 70. Romer Labs Recent Developments
 Table 71. Beijing Innotech Biotechnology Co., Ltd. Basic Information List
 Table 72. Beijing Innotech Biotechnology Co., Ltd. Description and Business Overview
 Table 73. Beijing Innotech Biotechnology Co., Ltd. Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Beijing Innotech Biotechnology Co., Ltd. (2020-2025)
 Table 75. Beijing Innotech Biotechnology Co., Ltd. Recent Developments
 Table 76. Livzon Reagent Basic Information List
 Table 77. Livzon Reagent Description and Business Overview
 Table 78. Livzon Reagent Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Livzon Reagent (2020-2025)
 Table 80. Livzon Reagent Recent Developments
 Table 81. Sanxiang Biology Basic Information List
 Table 82. Sanxiang Biology Description and Business Overview
 Table 83. Sanxiang Biology Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Sanxiang Biology (2020-2025)
 Table 85. Sanxiang Biology Recent Developments
 Table 86. Wondfo Bio Basic Information List
 Table 87. Wondfo Bio Description and Business Overview
 Table 88. Wondfo Bio Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Wondfo Bio (2020-2025)
 Table 90. Wondfo Bio Recent Developments
 Table 91. Wantai Bio Basic Information List
 Table 92. Wantai Bio Description and Business Overview
 Table 93. Wantai Bio Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Wantai Bio (2020-2025)
 Table 95. Wantai Bio Recent Developments
 Table 96. Oriental Creatures Basic Information List
 Table 97. Oriental Creatures Description and Business Overview
 Table 98. Oriental Creatures Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Oriental Creatures (2020-2025)
 Table 100. Oriental Creatures Recent Developments
 Table 101. Zhuo Cheng Huisheng Basic Information List
 Table 102. Zhuo Cheng Huisheng Description and Business Overview
 Table 103. Zhuo Cheng Huisheng Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Zhuo Cheng Huisheng (2020-2025)
 Table 105. Zhuo Cheng Huisheng Recent Developments
 Table 106. Hirsch Basic Information List
 Table 107. Hirsch Description and Business Overview
 Table 108. Hirsch Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Hirsch (2020-2025)
 Table 110. Hirsch Recent Developments
 Table 111. Boao Crystal Core Basic Information List
 Table 112. Boao Crystal Core Description and Business Overview
 Table 113. Boao Crystal Core Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Boao Crystal Core (2020-2025)
 Table 115. Boao Crystal Core Recent Developments
 Table 116. Wuhan Zhongqi Basic Information List
 Table 117. Wuhan Zhongqi Description and Business Overview
 Table 118. Wuhan Zhongqi Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Wuhan Zhongqi (2020-2025)
 Table 120. Wuhan Zhongqi Recent Developments
 Table 121. Yahuilong Basic Information List
 Table 122. Yahuilong Description and Business Overview
 Table 123. Yahuilong Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 124. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Yahuilong (2020-2025)
 Table 125. Yahuilong Recent Developments
 Table 126. Anxu Biology Basic Information List
 Table 127. Anxu Biology Description and Business Overview
 Table 128. Anxu Biology Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 129. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Anxu Biology (2020-2025)
 Table 130. Anxu Biology Recent Developments
 Table 131. Botuo Biological Basic Information List
 Table 132. Botuo Biological Description and Business Overview
 Table 133. Botuo Biological Rapid Testing for Respiratory Pathogens Products, Services and Solutions
 Table 134. Revenue (US$ Million) in Rapid Testing for Respiratory Pathogens Business of Botuo Biological (2020-2025)
 Table 135. Botuo Biological Recent Developments
 Table 136. Key Raw Materials Lists
 Table 137. Raw Materials Key Suppliers Lists
 Table 138. Rapid Testing for Respiratory Pathogens Downstream Customers
 Table 139. Rapid Testing for Respiratory Pathogens Distributors List
 Table 140. Research Programs/Design for This Report
 Table 141. Key Data Information from Secondary Sources
 Table 142. Key Data Information from Primary Sources
 Table 143. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Rapid Testing for Respiratory Pathogens Product Picture
 Figure 2. Global Rapid Testing for Respiratory Pathogens Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Rapid Testing for Respiratory Pathogens Sales Value (2020-2031) & (US$ Million)
 Figure 4. Rapid Testing for Respiratory Pathogens Report Years Considered
 Figure 5. Global Rapid Testing for Respiratory Pathogens Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Rapid Testing for Respiratory Pathogens Revenue in 2024
 Figure 7. Rapid Testing for Respiratory Pathogens Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. PCR Detection Picture
 Figure 9. RDT Detection Picture
 Figure 10. Other Picture
 Figure 11. Global Rapid Testing for Respiratory Pathogens Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 12. Global Rapid Testing for Respiratory Pathogens Sales Value Market Share by Type, 2024 & 2031
 Figure 13. Product Picture of Hospital
 Figure 14. Product Picture of Clinic
 Figure 15. Product Picture of Other
 Figure 16. Global Rapid Testing for Respiratory Pathogens Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global Rapid Testing for Respiratory Pathogens Sales Value Market Share by Application, 2024 & 2031
 Figure 18. North America Rapid Testing for Respiratory Pathogens Sales Value (2020-2031) & (US$ Million)
 Figure 19. North America Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
 Figure 20. Europe Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 21. Europe Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
 Figure 22. Asia Pacific Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 23. Asia Pacific Rapid Testing for Respiratory Pathogens Sales Value by Region (%), 2024 VS 2031
 Figure 24. South America Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 25. South America Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
 Figure 26. Middle East & Africa Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 27. Middle East & Africa Rapid Testing for Respiratory Pathogens Sales Value by Country (%), 2024 VS 2031
 Figure 28. Key Countries/Regions Rapid Testing for Respiratory Pathogens Sales Value (%), (2020-2031)
 Figure 29. United States Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 30. United States Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 31. United States Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 32. Europe Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Europe Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 34. Europe Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 35. China Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 36. China Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 37. China Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 38. Japan Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 39. Japan Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 40. Japan Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 41. South Korea Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 42. South Korea Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 43. South Korea Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 44. Southeast Asia Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 46. Southeast Asia Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 47. India Rapid Testing for Respiratory Pathogens Sales Value, (2020-2031) & (US$ Million)
 Figure 48. India Rapid Testing for Respiratory Pathogens Sales Value by Type (%), 2024 VS 2031
 Figure 49. India Rapid Testing for Respiratory Pathogens Sales Value by Application (%), 2024 VS 2031
 Figure 50. Rapid Testing for Respiratory Pathogens Industrial Chain
 Figure 51. Rapid Testing for Respiratory Pathogens Manufacturing Cost Structure
 Figure 52. Channels of Distribution (Direct Sales, and Distribution)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Juvenile Health Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33E5809
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Environmental Health & Safety (EHS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38B5948
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Posture Correction Belt Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5A1812
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Preventable Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24I3067
Wed Sep 10 00:00:00 UTC 2025

Add to Cart